Roth Capital Starts CymaBay Therapeutic (CBAY) at Buy
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 37 | New: 37
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 37 | New: 37
Join SI Premium – FREE
Roth Capital initiated coverage on CymaBay Therapeutic (NASDAQ: CBAY) with a Buy rating and a price target of $14.00.
For an analyst ratings summary and ratings history on CymaBay Therapeutic click here. For more ratings news on CymaBay Therapeutic click here.
Shares of CymaBay Therapeutic closed at $7.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts Csquare Inc (CSQR) at Overweight
- Wells Fargo Assumes Pinnacle Financial Partners (PNFP) at Equal Weight
- Wells Fargo Assumes UMB Financial (UMBF) at Equal Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
